FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers Read more
Maze Therapeutics Launches with $191 Million to Focus on Translating Genetic Insights into New Medicines Read more
AbCellera and Denali Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases Read more
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies Read more